Structural requirements for Decay Acclerating Activity (DAA) in complement receptor 1 (CR1; CD35)

Author: Krych-Goldberg M.   Hauhart R.   Blackmer D.   Atkinson J.P.  

Publisher: Elsevier

ISSN: 0162-3109

Source: Immunopharmacology, Vol.49, Iss.1, 2000-08, pp. : 62-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next